Expression of Vascular Endothelial Growth Factor C in Laryngeal Squamous Carcinoma and Its Role in Lymphatic Metastasis

Journal of Sichuan University (Medical Science)

Volumn 35, Issue 1, 2004, Pages 47-49

  Wang, Zhong Liang ^a   Chen, Yao ^b   Zhou, Bin ^b   Liang, Chuan Yu ^b   Zhang, Lin ^b   Li, Ruixiang ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Immunohistochemistry; Laryngeal squamous carcinoma; Lymphatic metastasis; Vascular endothelial growth factor C

Indexed keywords

PARAFFIN; VASCULOTROPIN C;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

EID: 1642446686     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Veikkola T, Alitalo K. VEGFs receptors and angiogenesis. Semin Cancer Biol, 1999; 9 (3):211.
2. Joukov V, Pajusola K, Kaipainen A, et al. A new vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 1996; 15(2):290.
3. Eriksson U, Alitalo K. Structure expression and receptor-binding properties of novel vascular endothelial growth factors. In: Claesson-Welsb L, editor. Vascular growth factors and angiogenesis. Berlin: Springer-Verlag, 1999:41-57.
4. Ogawa S, Oku A, Sawano A, et al. A novel type of vascular endothelial factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem, 1998; 273(47):31273.
5. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science, 1997; 276(5317):1423.
6. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase Flt4 gene becomes restricted to endothelium of lymphatic vessels during development. Proc Natl Acad Sci USA, 1995; 92(8):3566.
7. Fellmer PT, Sato K, Tanaka R, et al. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery, 1999; 126(6):1056.
8. Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer, 1999; 80(1-2):309.